Patents by Inventor Julie MACOIN

Julie MACOIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20240327530
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: March 8, 2024
    Publication date: October 3, 2024
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA
  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20240327531
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: March 8, 2024
    Publication date: October 3, 2024
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA
  • CD3/BCMA/CD38 Trispecific Antibodies
    Publication number: 20240228650
    Abstract: The present invention relates to novel trispecific heterodimeric immunoglobulins. More specifically the present invention relates to trispecific heterodimeric immunoglobulins that target human CD3 antigen, human BCMA and human CD38 antigen. The present invention also relates to this novel class of trispecific heterodimeric immunoglobulins for use in the treatment of proliferative diseases and in particular cancers such as hematological cancer. The present invention relates to novel trispecific antibody for use in treating multiple myeloma.
    Type: Application
    Filed: May 4, 2023
    Publication date: July 11, 2024
    Inventors: Maria PIHLGREN BOSCH, Mario PERRO, Olivia HALL, Laura CARRETERO IGLESIA, Adam DRAKE, Daniela PAIS, Rebecca CROASDALE-WOOD, Jérémy LOYAU, Carole ESTOPPEY, Ankita SRIVASTAVA, Michael DYSON, Julie MACOIN, Myriam CHIMEN, Thierry MONNEY, Cyrille DREYFUS
  • Antibodies that bind to IL1RAP and uses thereof
    Patent number: 11970539
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and may also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: April 30, 2024
    Assignee: Ichnos Sciences SA
    Inventors: Julie Macoin, Amelie Croset, Jeremy Loyau, Thierry Monney, Lamine Mbow, Marie-Agnes Doucey, Valentina Labanca
  • CD3/BCMA/CD38 Trispecific Antibodies
    Publication number: 20240132615
    Abstract: The present invention relates to novel trispecific heterodimeric immunoglobulins. More specifically the present invention relates to trispecific heterodimeric immunoglobulins that target human CD3 antigen, human BCMA and human CD38 antigen. The present invention also relates to this novel class of trispecific heterodimeric immunoglobulins for use in the treatment of proliferative diseases and in particular cancers such as hematological cancer. The present invention relates to novel trispecific antibody for use in treating multiple myeloma.
    Type: Application
    Filed: May 3, 2023
    Publication date: April 25, 2024
    Inventors: Maria PIHLGREN BOSCH, Mario PERRO, Olivia HALL, Laura CARRETERO IGLESIA, Adam DRAKE, Daniela PAIS, Rebecca CROASDALE-WOOD, Jérémy LOYAU, Carole ESTOPPEY, Ankita SRIVASTAVA, Michael DYSON, Julie MACOIN, Myriam CHIMEN, Thierry MONNEY, Cyrille DREYFUS
  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20220089754
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: March 24, 2022
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA
  • NOVEL TNFR AGONISTS AND USES THEREOF
    Publication number: 20200347143
    Abstract: The present invention relates to a new class of TNFR agonist comprising multiple binding portions to two different parts of the same TNFR. The present invention also relates to methods of activating components of the immune system in a patient via the administration of a TNFR agonist according to the present invention as well as the use of such materials for further therapeutic and other purposes.
    Type: Application
    Filed: December 19, 2017
    Publication date: November 5, 2020
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Stanislas BLEIN, Francois ROUSSEAU, Rami LISSILAA, Jonathan BACK, Julie MACOIN